Apg Asset Management N.V. Gilead Sciences, Inc. Transaction History

Apg Asset Management N.V.

$61 Billion
Q1 2024

A detailed history of Apg Asset Management N.V. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Apg Asset Management N.V. holds 2,387,027 shares of GILD stock, worth $163 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

2,387,027

Previous 2,369,928 0.72%

Holding current value

$163 Million

Previous $192 Million 8.93%

% of portfolio

0.29%

Previous 0.34%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $1.22 Million - $1.49 Million	17,099 Added 0.72%	2,387,027 $175 Million
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $17.8 Million - $20.2 Million	-242,620 Reduced 9.29%	2,369,928 $192 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $3.07 Million - $3.35 Million	-41,493 Reduced 1.56%	2,612,548 $196 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $5 Million - $5.7 Million	65,744 Added 2.54%	2,654,041 $205 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $24 Million - $27.4 Million	-310,689 Reduced 10.72%	2,588,297 $215 Million

Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $58.7 Million - $84.2 Million	941,459 Added 48.09%	2,898,986 $249 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $61.7 Million - $70.4 Million	-1,035,617 Reduced 34.6%	1,957,527 $123 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $715,554 - $805,928	-12,397 Reduced 0.41%	2,993,144 $177 Million
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $19 Million - $23.8 Million	-327,500 Reduced 9.83%	3,005,541 $161 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $1.62 Million - $1.84 Million	-25,000 Reduced 0.74%	3,333,041 $213 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $13.6 Million - $14.7 Million	-200,700 Reduced 5.64%	3,358,041 $202 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $14.5 Million - $15.8 Million	-228,378 Reduced 6.03%	3,558,741 $207 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $12 Million - $13.7 Million	-200,791 Reduced 5.03%	3,787,119 $208 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $65.4 Million - $74.6 Million	1,155,168 Added 40.78%	3,987,910 $190 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $2.94 Million - $3.7 Million	47,352 Added 1.7%	2,832,742 $153 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $120 Million - $139 Million	1,652,188 Added 145.8%	2,785,390 $191 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $80.4 Million - $103 Million	-1,283,973 Reduced 53.12%	1,133,202 $84.7 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $107 Million - $137 Million	1,701,818 Added 237.9%	2,417,175 $140 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $9.22 Million - $10.1 Million	149,669 Added 26.46%	715,357 $41.4 Million
Q3 2019 Nov 08, 2019	BUY	$62.51 - $69.0 $8.64 Million - $9.54 Million	138,208 Added 32.33%	565,688 $32.9 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $123 Million - $138 Million	-1,989,695 Reduced 82.31%	427,480 $25.4 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $164 Million - $184 Million	-2,619,655 Reduced 52.01%	2,417,175 $140 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $11.5 Million - $15 Million	-190,200 Reduced 3.64%	5,036,830 $276 Million
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $1.55 Million - $1.71 Million	21,700 Added 0.42%	5,227,030 $347 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $19.3 Million - $22.5 Million	-297,800 Reduced 5.41%	5,205,330 $316 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $20.1 Million - $24.5 Million	-275,900 Reduced 4.77%	5,503,130 $337 Million
Q4 2017 Jan 24, 2018	BUY	$71.15 - $83.52 $1.77 Million - $2.07 Million	24,816 Added 0.43%	5,779,030 $345 Million
Q3 2017 Oct 19, 2017	BUY	$72.11 - $85.47 $415 Million - $492 Million	5,754,214	5,754,214 $466 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.

Account

Apg Asset Management N.V. Gilead Sciences, Inc. Transaction History